Prostate cancer is the second-leading cause of cancer death among American men. With 1 in 8 facing this diagnosis over his ...

While this cancer often progresses slowly and may not require immediate treatment, it can be aggressive and spread to other ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Prostate cancer, a significant health concern, is projected to rise in India, with cases expected to double by 2040. Family ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

We’re finding that plant-derived substances may one day be used to support traditional cancer treatment and prevention ...

Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell competition.

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

Chunhui Han, PhD, discusses the potential feasibility of the integration of Gallium 68 PSMA-11 in biology-guided radiotherapy ...